Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition
- PMID: 9544905
- DOI: 10.1016/s0022-3476(98)70024-1
Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition
Abstract
Objectives: The objectives of this study were to determine growth status and to identify malnutrition with various anthropometric indicators in children with cystic fibrosis (CF) based on cross-sectional analysis of the 1993 National CF Patient Registry data.
Methods: Heights and weights of 13,116 children with CF were evaluated with percentile, percent of reference median, Z-score, and percent ideal weight-for-height based on National Center for Health Statistics/Centers for Disease Control growth references. Malnutrition was defined by four criteria: (1) height-for-age <5th percentile ("stunting") or weight-for-age <5th percentile ("wasting") (2) height-for-age <90% of reference median or weight-for-age <80% of reference median, (3) height-for-age <5th percentile or percent ideal weight-for-height <85%, and (4) height-for-age <90% of reference median or weight-for-height <85% of reference median.
Results: Mean and median height- and weight-for-age were found to be at the 30th and 20th percentiles in children with CF. Malnutrition (height- or weight-for-age <5th percentile) was particularly pronounced in infants (47%) and adolescents (34%) and patients with newly diagnosed CF (44%). A significant sex difference (p < 0.01) in the occurrence of stunting (height-for-age <5th percentile) was observed during adolescence: boys 11 to 14 years of age showed lower occurrence of stunting (19%) compared with girls (29%), whereas the opposite trend was observed at 15 to 18 years (34% in male patients vs 28% in female patients).
Conclusion: Twenty percent of all children in the 1993 National CF Patient Registry were <5th percentile for height- or weight-for-age. A significant discrepancy was found when different criteria were used to distinguish "stunting" versus "wasting" in malnourished children with CF.
Similar articles
-
Nutritional status of children with cystic fibrosis measured by total body potassium as a marker of body cell mass: lack of sensitivity of anthropometric measures.J Pediatr. 2000 Feb;136(2):188-94. doi: 10.1016/s0022-3476(00)70100-4. J Pediatr. 2000. PMID: 10657824
-
Growth assessment of paediatric patients with CF comparing different auxologic indicators: A multicentre Italian study.J Pediatr Gastroenterol Nutr. 2009 Sep;49(3):335-42. doi: 10.1097/MPG.0b013e31818f0a39. J Pediatr Gastroenterol Nutr. 2009. PMID: 19543116
-
Evaluation of body mass index percentiles for assessment of malnutrition in children with cystic fibrosis.Eur J Clin Nutr. 2007 Jun;61(6):759-68. doi: 10.1038/sj.ejcn.1602582. Epub 2007 Jan 10. Eur J Clin Nutr. 2007. PMID: 17213872
-
Classification of nutritional status in cystic fibrosis.Curr Opin Pulm Med. 2006 Nov;12(6):422-7. doi: 10.1097/01.mcp.0000245709.66762.f9. Curr Opin Pulm Med. 2006. PMID: 17053492 Review.
-
[WHO growth standards for infants and young children].Arch Pediatr. 2009 Jan;16(1):47-53. doi: 10.1016/j.arcped.2008.10.010. Epub 2008 Nov 25. Arch Pediatr. 2009. PMID: 19036567 Review. French.
Cited by
-
Can Existing Knowledge on Eating Behaviors and Obesity Support People with Cystic Fibrosis Who Are Nutritionally Compromised?Front Psychol. 2016 Sep 27;7:1477. doi: 10.3389/fpsyg.2016.01477. eCollection 2016. Front Psychol. 2016. PMID: 27729893 Free PMC article. No abstract available.
-
Evaluation of a five-year predicted survival model for cystic fibrosis in later time periods.Sci Rep. 2020 Apr 20;10(1):6602. doi: 10.1038/s41598-020-63590-8. Sci Rep. 2020. PMID: 32313191 Free PMC article.
-
Endocrine Disorders in Cystic Fibrosis.Pediatr Clin North Am. 2016 Aug;63(4):699-708. doi: 10.1016/j.pcl.2016.04.009. Pediatr Clin North Am. 2016. PMID: 27469183 Free PMC article. Review.
-
The cystic fibrosis transmembrane conductance regulator (Cftr) modulates the timing of puberty in mice.J Med Genet. 2006 Jun;43(6):e29. doi: 10.1136/jmg.2005.032839. J Med Genet. 2006. PMID: 16740913 Free PMC article.
-
Survival effect of lung transplantation among patients with cystic fibrosis.JAMA. 2001 Dec 5;286(21):2683-9. doi: 10.1001/jama.286.21.2683. JAMA. 2001. PMID: 11730443 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical